<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Frequent induction of chromosomal aberrations in in vivo skin fibroblasts after allogeneic stem cell transplantation: hints to chromosomal instability after irradiation</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><forename type="first">G</forename><surname>Massenkeil</surname></persName>
							<email>gero.massenkeil@klinikum-guetersloh.de</email>
							<affiliation key="aff0">
								<orgName type="department">Department of Hematology, Oncology and Tumor Immunology</orgName>
								<orgName type="institution">Charité Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Department of Internal Medicine</orgName>
								<orgName type="department" key="dep2">Clinic for Hematology and Oncology</orgName>
								<orgName type="institution">Klinikum Guetersloh</orgName>
								<address>
									<settlement>Guetersloh</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Department of Hematology, Oncology and Tumor Immunology</orgName>
								<orgName type="institution">Charité Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">P</forename><surname>Zschieschang</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Institute for Medical Genetics</orgName>
								<orgName type="institution">Charité Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">G</forename><surname>Thiel</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Institute for Medical Genetics</orgName>
								<orgName type="institution">Charité Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">P</forename><forename type="middle">G</forename><surname>Hemmati</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Hematology, Oncology and Tumor Immunology</orgName>
								<orgName type="institution">Charité Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Department of Hematology, Oncology and Tumor Immunology</orgName>
								<orgName type="institution">Charité Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">V</forename><surname>Budach</surname></persName>
							<affiliation key="aff4">
								<orgName type="department">Clinic for Radiation Oncology</orgName>
								<orgName type="institution">Charité Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">B</forename><surname>Dörken</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Hematology, Oncology and Tumor Immunology</orgName>
								<orgName type="institution">Charité Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Department of Hematology, Oncology and Tumor Immunology</orgName>
								<orgName type="institution">Charité Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">J</forename><surname>Pross</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Hematology, Oncology and Tumor Immunology</orgName>
								<orgName type="institution">Charité Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Department of Hematology, Oncology and Tumor Immunology</orgName>
								<orgName type="institution">Charité Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">R</forename><surname>Arnold</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Hematology, Oncology and Tumor Immunology</orgName>
								<orgName type="institution">Charité Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Department of Hematology, Oncology and Tumor Immunology</orgName>
								<orgName type="institution">Charité Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff5">
								<orgName type="department" key="dep1">Department of Internal Medicine</orgName>
								<orgName type="department" key="dep2">Clinic for Hematology and Oncology</orgName>
								<orgName type="institution">Klinikum Guetersloh</orgName>
								<address>
									<settlement>Guetersloh</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff6">
								<orgName type="department">Medical practice for Human Genetics</orgName>
								<address>
									<settlement>Friedrichstrasse, Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Frequent induction of chromosomal aberrations in in vivo skin fibroblasts after allogeneic stem cell transplantation: hints to chromosomal instability after irradiation</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">77F60F5FB8D3292E946CB23E7D4FA23B</idno>
					<idno type="DOI">10.1186/s13014-015-0576-4</idno>
					<note type="submission">Received: 22 December 2014 Accepted: 21 December 2015</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:09+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Chromosomal aberrations</term>
					<term>Skin fibroblasts</term>
					<term>Allogeneic stem cell transplantation</term>
					<term>Total body irradiation</term>
					<term>Radiation-induced chromosomal instability</term>
					<term>Secondary malignancies</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Background: Total body irradiation (TBI) has been part of standard conditioning regimens before allogeneic stem cell transplantation for many years.</s><s>Its effect on normal tissue in these patients has not been studied extensively.</s><s>Method: We studied the in vivo cytogenetic effects of TBI and high-dose chemotherapy on skin fibroblasts from 35 allogeneic stem cell transplantation (SCT) patients.</s><s>Biopsies were obtained prospectively (n = 18 patients) before, 3 and 12 months after allogeneic SCT and retrospectively (n = 17 patients) 23-65 months after SCT for G-banded chromosome analysis.</s></p><p><s>Results: Chromosomal aberrations were detected in 2/18 patients (11 %) before allogeneic SCT, in 12/13 patients (92 %) after 3 months, in all patients after 12 months and in all patients in the retrospective group after allogeneic SCT.</s><s>The percentage of aberrant cells was significantly higher at all times after allogeneic SCT compared to baseline analysis.</s><s>Reciprocal translocations were the most common aberrations, but all other types of stable, structural chromosomal aberrations were also observed.</s><s>Clonal aberrations were observed, but only in three cases they were detected in independently cultured flasks.</s><s>A tendency to non-random clustering throughout the genome was observed.</s><s>The percentage of aberrant cells was not different between patients with and without secondary malignancies in this study group.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusion:</head><p><s>High-dose chemotherapy and TBI leads to severe chromosomal damage in skin fibroblasts of patients after SCT.</s><s>Our long-term data suggest that this damage increases with time, possibly due to in vivo radiationinduced chromosomal instability.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>The most worrisome long-term side effect after successful allogeneic SCT (SCT) is the increased risk of secondary malignancies.</s></p><p><s>These tumors develop several years after transplantation with rising incidence over time.</s><s>Besides younger age at transplantation and chronic immunosuppression through chronic graft-versus-host disease (GvHD), intensive conditioning treatment with total body irradiation (TBI) and high-dose chemotherapy has emerged as a prominent risk factor after allogeneic SCT <ref type="bibr" target="#b0">[1]</ref><ref type="bibr" target="#b1">[2]</ref><ref type="bibr" target="#b2">[3]</ref><ref type="bibr" target="#b3">[4]</ref><ref type="bibr" target="#b4">[5]</ref><ref type="bibr" target="#b5">[6]</ref><ref type="bibr" target="#b6">[7]</ref>.</s></p><p><s>Ionizing radiation has the capacity to induce chromosomal aberrations in a variety of human tissues.</s><s>Specific chromosomal aberrations in blood cells like losses at chromosomes 5 and 7, inv(16)(p13q22) and aberrations involving 11q23, 17q21, or 21q22 have been identified in chemotherapy-related myelodysplastic syndromes or acute myeloid leukemias after chemotherapy as well as after radioiodine therapy for malignant or benign thyroid disease <ref type="bibr" target="#b7">[8]</ref><ref type="bibr" target="#b8">[9]</ref><ref type="bibr" target="#b9">[10]</ref><ref type="bibr" target="#b10">[11]</ref>.</s><s>Less cytogenetic data in secondary solid tumors after radiotherapy are available, showing a diverse spectrum from simple balanced translocations to complex aberrant karyotypes in few cases <ref type="bibr" target="#b11">[12]</ref>.</s><s>Sublethal genomic damage may induce repairing cellular mechanisms after various times of cell cycle arrest or propagation of genetic lesions, which could ultimately lead to malignant transformation <ref type="bibr" target="#b12">[13]</ref>.</s><s>Evidence has accumulated that DNA-damage not only occurs in directly irradiated cells, but also in the progeny of the irradiated cells at delayed times after radiation exposure <ref type="bibr" target="#b12">[13,</ref><ref type="bibr" target="#b13">14]</ref>.</s></p><p><s>Chromosomal aberrations have been described in cultured skin fibroblasts after accidental irradiation in single patients <ref type="bibr" target="#b14">[15,</ref><ref type="bibr" target="#b15">16]</ref> and in a few patients having received radiotherapy <ref type="bibr" target="#b16">[17]</ref><ref type="bibr" target="#b17">[18]</ref><ref type="bibr" target="#b18">[19]</ref>.</s><s>No systemic in vivo cytogenetic analysis of irradiated skin fibroblasts has been performed in patients.</s></p><p><s>We investigated the development of cytogenetic aberrations in skin fibroblasts from hematologic patients after conditioning with high-dose chemotherapy and fractionated TBI for allogeneic SCT.</s><s>A prospective patient cohort was studied before and after allogeneic SCT by taking sequential skin biopsies for chromosomal analysis.</s><s>Another group of patients, who had received the identical standard high-dose conditioning therapy before allogeneic SCT was studied retrospectively.</s><s>To our knowledge, this is the first larger prospective as well as retrospective study with a long-term follow-up on in vivo induction of cytogenetic aberrations after irradiation.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Patients and methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Patients</head><p><s>Forty-six allogeneic stem cell transplant patients were included in the study.</s><s>Final analysis comprised 35 of these 46 patients, because 11 of 46 patients were excluded from further analysis for the following reasons: no total body irradiation as part of the conditioning protocol before allogeneic SCT (n = 2), equivocal allocation of probes (n = 2), insufficient growth of fibroblasts (n = 3), metaphases not evaluable after preparation (n = 2), early death before 3 months after allogeneic SCT (n = 2).</s></p><p><s>The prospective study group consisted of 18/35 patients.</s><s>Skin biopsies were taken at three time points: immediately before high-dose conditioning, 3 months and 12 months after allogeneic SCT.</s></p><p><s>The retrospective study group comprised 17/35 patients.</s><s>Skin biopsies were obtained once from each patient, in median 38 months after SCT (range 23 to 65 months) (Table <ref type="table" target="#tab_0">1</ref>).</s><s>The study was approved by the local ethical committee of the Charité Universitätsmedizin Berlin.</s><s>All patients gave written informed consent.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conditioning regimen</head><p><s>All patients underwent standard high-dose conditioning with fractionated TBI with 6x2 gray (Gy) on three consecutive days and high-dose cyclophosphamide and / or etoposide <ref type="bibr" target="#b19">[20]</ref>.</s><s>Three patients in the prospective group were treated with antithymocyte globulin (ATG, Fresenius, Germany) (3x20 mg/kg) before SCT because of an increased risk of graft failure due to a single HLAmismatch.</s></p><p><s>One patient with MDS received additional local radiotherapy to thoracic skin areas and spleen because of biopsy-proven skin infiltrates and enormous splenomegaly.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>GvHD prophylaxis</head><p><s>Patients with a related donor received cyclosporine A (CSA) for approximately 6 months plus short-course methotrexate (MTX) i.v. or prednisone.</s><s>In patients with unrelated or mismatch donors, GvHD prophylaxis consisted of CSA, MTX and prednisone.</s><s>Prednisone was tapered off after day 28.</s><s>Legend to Table <ref type="table" target="#tab_0">1</ref>: *One patient did not proceed to transplantation due to rapidly progressing disease at admission and was therefore only considered for the cytogenetic analysis before SCT</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Processing of skin biopsies</head><p><s>After local anesthesia with lidocaine (1 %), skin samples were obtained as 4 mm punch biopsies.</s><s>Most biopsies were taken from the upper back.</s><s>Skin samples were cut into small pieces and placed at the bottom of two culture flasks.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Fibroblast cultures</head><p><s>Fibroblasts were cultured in fetal calf serum and incubated at 37 °C with 5 % CO 2 -pressure according to standard techniques <ref type="bibr" target="#b20">[21]</ref>.</s><s>Culture medium was changed weekly and cultures were checked regularly for typical fibroblast growth.</s><s>When sufficient fibroblasts were grown, they were washed, trypsinized and passed to two larger flasks to induce a synchronous cell division.</s><s>As fibroblasts divide every 16-28 hours in culture, cells were harvested after another 2-3 days, when they changed from a spindle-shaped to a spheroidal form indicating mitosis <ref type="bibr" target="#b21">[22]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Chromosomal preparation</head><p><s>Colcemide was used to arrest cells in metaphase.</s><s>After trypsinization, cells were centrifuged and resuspended.</s><s>Warmed hypotonic solution was slowly added on a shaker and cells were incubated for 20 minutes and then fixed and incubated for another 10 minutes.</s><s>At least five rounds of fixation, incubation, centrifugation and resuspension were repeated before cells were applied onto an object plate and dried.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Staining of metaphases</head><p><s>Banding was carried out using Trypsin-Giemsa-banding technique <ref type="bibr" target="#b22">[23]</ref>.</s><s>Plates were incubated for 1 hour at 80 °C.</s><s>In a first step, object plates were incubated at 20 °C with trypsin and isotonic PBS (phosphate-buffered saline).</s><s>After rinsing, they were then incubated for 4 minutes in Giemsa staining solution, dried and covered.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cytogenetic analysis</head><p><s>For each skin sample, 30 metaphases representing 30 cells in vitro were analyzed from the prepared slides.</s><s>Whenever cells from two separate culture flasks were available, 15 metaphases were analyzed from each flask.</s><s>Karyotypes were defined according to the International System for Human Cytogenetic Nomenclature <ref type="bibr" target="#b23">[24]</ref>.</s><s>For each skin sample, the percentage of aberrant cells and the mean number of breakpoints per aberrant cell were determined from the 30 selected metaphases.</s><s>If identical aberrations were detected in two or more metaphases, they were regarded as clonal as defined by others <ref type="bibr" target="#b16">[17,</ref><ref type="bibr" target="#b24">25]</ref>.</s><s>We separately registered identical aberrations in only one or in both of the flasks set up from one biopsy.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistics</head><p><s>Results of the descriptive analysis are given in median and range.</s></p><p><s>In order to compare the frequencies of patients with aberrant cells, McNemar-Test was used within the prospective study group.</s></p><p><s>In order to compare the results of different time points within the prospective study group including the number of aberrant metaphases per 30 metaphases (= the percentage of aberrant cells) and the mean number of breakpoints per aberrant metaphase, a non-parametric factorial analysis for repeated measurements and Wilcoxon rank sum test for paired data were used.</s><s>To compare different clinical subgroups, Mann-Whitney U Test was performed.</s><s>Data were analyzed using statistical software (SPSS, version 11.0; SAS, version 8.2).</s><s>Significance was always assessed at the p &lt; 0.05 level, two-sided.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Metaphase analysis</head><p><s>In the prospective group, chromosomal aberrations were observed in only two out of 18 patients before SCT.</s><s>The percentage of aberrant cells was rather low in these two patients and only one clone with a single reciprocal translocation was found, namely t(12;18) in one and t <ref type="bibr">(5;17)</ref> in the other patient.</s><s>One of these patients had received prophylactic cranial irradiation prior to SCT (24 Gy) due to ALL.</s></p><p><s>Three months after SCT, 12 out of 13 patients had aberrant cells in cytogenetic fibroblast analysis, and 12 months after SCT, all patients displayed cytogenetic aberrations.</s><s>The number of patients with aberrant cells was significantly higher after SCT at both time points compared to the number of affected patients before SCT (Table <ref type="table" target="#tab_1">2</ref>).</s></p><p><s>All 17 patients (100 %) in the retrospective group had an aberrant karyotype.</s></p><p><s>77 % of cells were aberrant three months and 63 % in median 12 months after SCT.</s><s>Difference between 3 and 12 months after SCT was not significant (p = 0.237, Wilcoxon test), but difference between pre-SCT analysis and both time points after SCT was highly significant.</s></p><p><s>In the retrospective group, a median of 83 % of the analyzed cells was aberrant (Table <ref type="table" target="#tab_1">2</ref>).</s></p><p><s>The mean number of breakpoints per aberrant cell was too small to allow statistical testing (Table <ref type="table" target="#tab_1">2</ref>).</s></p><p><s>82 -94 % of the chromosomal aberrations observed in the prospective and retrospective group were detected in 2 or more cells from one sample and were thus defined as clonal.</s><s>Most of them were found in only one of the two flasks, however.</s><s>The frequency of clonal aberrations was not different between the single time points (data not shown).</s><s>In three patients, we detected cells with identical cytogenetic aberrations in cultures from independently set up pieces of the same biopsy (i.e. in two separately cultured flasks).</s><s>Karyotype evolution could be observed in 13 patients in our study: in addition to the original aberration(s) defining a clone as such, some cells had acquired further cytogenetic aberrations.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Types of chromosomal aberrations</head><p><s>Only stable, structural chromosomal aberrations were detected.</s><s>Reciprocal translocations were the most common aberrations, but deletions, additional material of unknown origin, inversions, insertions, derivative and marker chromosomes were also observed.</s><s>Unstable or numerical aberrations were not seen (Fig. <ref type="figure">1</ref>).</s><s>Complex aberrations as defined <ref type="bibr" target="#b25">[26]</ref> were identified in five out of 13 patients 3 months after SCT, 2/11 at 12 months after SCT and 8/17 in the retrospective group.</s><s>Apart from several three-break-translocations, we observed one four-break-translocation (the latter in the retrospective study group).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Breakpoint analysis</head><p><s>Chromosomal breakpoints affected all chromosomes in both groups (except for chromosome Y in the retrospective group) and are illustrated in idiograms (Figs. <ref type="figure" target="#fig_2">2  and 3</ref>). Figure <ref type="figure">2</ref> shows the breakpoints for the three time points in the prospective group.</s><s>In Fig. <ref type="figure" target="#fig_2">3</ref>, breakpoints of the retrospective group are displayed.</s><s>Breakpoints observed in clonal aberrations were only counted once for each clone.</s></p><p><s>There was a tendency to a clustering at a number of chromosome bands.</s><s>We defined a cluster as a chromosomal band, where at least five breaks were detected (coming from at least 3 different patients) <ref type="bibr" target="#b26">[27]</ref>.</s><s>15 clusters were detected in the prospective study group and 11 in the retrospective group.</s><s>In Table <ref type="table" target="#tab_2">3</ref>, the observed and expected percentages of breakpoints for the different chromosomes are shown for the different time points.</s><s>The expected percentages were calculated assuming that the distribution of breakpoints is proportional to physical length of chromosomes <ref type="bibr" target="#b27">[28]</ref>.</s></p><p><s>A higher rate of breakpoints than expected was observed at chromosome arms 1p,1q and 14q (Table <ref type="table" target="#tab_2">3</ref>) <ref type="bibr" target="#b27">[28]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Clinical parameters and correlation with cytogenetic aberrations</head><p><s>The following clinical parameters were correlated with the percentage of aberrant cells and the mean number of breakpoints detected: patients' sex, underlying disease, donor type, GvHD of the skin and secondary tumors.</s></p><p><s>3 months after SCT, the percentage of aberrant cells was significantly higher in patients with acute leukemias compared to patients with other diagnoses (p = 0.028).</s><s>In the retrospective group as well, patients with acute leukemias had a higher mean number of breakpoints per aberrant cell as opposed to patients with other diagnoses (p = 0.027, Mann-Whitney U test).</s><s>All other analyses did not reach statistical significance.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Secondary malignancies and correlation with cytogenetic aberrations</head><p><s>With an updated follow-up of up to 14 years in the prospective and 18 years in the retrospective group, secondary malignancies affected 7 out of 35 patients, 2 in the prospective and 5 in the retrospective group.</s><s>Secondary malignancies developed 34 to 158 months (137 months in median) after allogeneic SCT.</s><s>Two patients had malignant melanoma, another 2 patients had oral squamous cell cancer, 1 patient had uterine cervical cancer, 1 patient had cholangiocellular carcinoma and 1 patient developed bladder cancer.</s><s>All patients had surgical resection of their secondary malignancies, 1 patient died due to progressive relapse of bladder cancer 3 months after tumor diagnosis, the others survived.</s><s>Follow-up in the seven patients was 22 months in median after diagnosis of secondary malignancy (3-61 months).</s><s>Another 4 patients had basal cell cancer of the skin 94 to 120 months after allogeneic SCT, which were successfully removed by surgery.</s><s>Legend to Table <ref type="table" target="#tab_1">2</ref>: pat.</s><s>= patients.</s><s>no.</s><s>= number. 1</s><s>Results are given in median and range. 2 Because only two patients had cytogenetic aberrations before SCT, median and range could not be given and only numbers of these two patients are shown.</s><s>NA = not applicable because of small number of statistical events  The percentage of aberrant cells in the retrospective group was not different between the five patients with secondary malignancies (80 % in median, range 67-93 %) and the ten patients without secondary malignancy (83 % in median, range 53-94 %).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>We herein describe the time-dependent development of cytogenetic damage induced in skin fibroblasts after conditioning with high-dose chemotherapy and TBI and allogeneic SCT in a larger cohort of patients with a long term follow-up.</s></p><p><s>The percentage of cells with an aberrant karyotype in our study was significantly higher at all time points after high-dose conditioning compared to the biopsies taken before conditioning.</s><s>Genetic damage occurred early, because most metaphases from biopsies taken 3 months after SCT already presented an aberrant karyotype.</s></p><p><s>It is unlikely, that all these aberrations developed ex vivo in culture, because most skin metaphases were normal before SCT.</s><s>In the literature there is only one small series of four pediatric patients after TBI or total lymphoid irradiation, where authors found 49 to 88 % aberrant metaphases in the skin biopsies taken within radiotherapy fields <ref type="bibr" target="#b18">[19]</ref>.</s><s>A few case reports have also been published describing chromosomal aberrations in skin fibroblasts after in vivo radiation exposure <ref type="bibr" target="#b14">[15]</ref><ref type="bibr" target="#b15">[16]</ref><ref type="bibr" target="#b16">[17]</ref><ref type="bibr" target="#b17">[18]</ref><ref type="bibr" target="#b24">25]</ref>, but without comparison to pre-radiation metaphases.</s><s>To our knowledge, our study is the largest in vivo cytogenetic study in irradiated patients with hematologic malignancies, which follows chromosomal aberrations over time.</s></p><p><s>Patients with acute leukemias, who had received more intensive chemotherapy before TBI had a higher level of cytogenetic damage.</s><s>Therefore it cannot be excluded that the extent of the observed cytogenetic damage in the present study may have been influenced in part by radiation enhancing effects of chemotherapy.</s><s>However in a small series of SCT-patients, abnormal karyotypes were only observed in those with TBI, but not in those without <ref type="bibr" target="#b18">[19]</ref>.</s></p><p><s>We mainly detected clonal aberrations in our study.</s><s>Most of them were only seen in single culture flasks, so that in vitro clone formation cannot be excluded.</s><s>A  stronger hint to in vivo clonality could be found in three of our patients with identical aberrations in cultures from independently set up pieces of the same biopsy.</s><s>Hints to in vivo clone formation come from case reports by others as well <ref type="bibr" target="#b14">[15,</ref><ref type="bibr" target="#b16">[17]</ref><ref type="bibr" target="#b17">[18]</ref><ref type="bibr" target="#b18">[19]</ref>.</s><s>The strongest evidence for in vivo clone formation was reported by Mouthuy and Dutrillaux, who found cells with identical aberrations in two skin biopsies, which were taken with a time interval of one year <ref type="bibr" target="#b14">[15]</ref>.</s><s>This is a unique finding neither confirmed by us nor others.</s><s>A clone is not necessarily completely homogenous since subclones may have evolved exhibiting additional aberrations <ref type="bibr" target="#b23">[24]</ref>.</s><s>This phenomenon described as karyotype evolution was observed in 13 patients of our study.</s></p><p><s>Reciprocal translocations were the most common type of aberration observed at all time points.</s><s>In 16 of our patients, complex aberrations were detected.</s><s>The most complex aberration was a four-break-translocation seen in a patient of the retrospective group.</s></p><p><s>The high rates of aberrations in our study, karyotype evolution and the presence of complex aberrations are in line with the concept of permanent genomic instability through the cytotoxic effects of irradiation <ref type="bibr" target="#b12">[13,</ref><ref type="bibr" target="#b13">14,</ref><ref type="bibr" target="#b28">29]</ref>.</s></p><p><s>Studies of in vitro irradiated fibroblasts have demonstrated that the radiation-induced breakpoints are distributed non-randomly throughout the genome <ref type="bibr" target="#b26">[27,</ref><ref type="bibr" target="#b29">30,</ref><ref type="bibr" target="#b30">31]</ref>.</s><s>In our study some of the clusters were detected at published breakpoints like, for example, 1p22.</s><s>Both arms of chromosome 1 have been affected frequently in in vitro studies of irradiated diploid cells <ref type="bibr" target="#b26">[27]</ref>.</s><s>We are reserved in the interpretation of the results of our breakpoint analysis on the basis of this conventional cytogenetic study.</s><s>We see hints for a non-random distribution of breakpoints in our study (Figs. <ref type="figure" target="#fig_2">2 and 3</ref>, Table <ref type="table" target="#tab_2">3</ref>).</s></p><p><s>Interestingly, several of the observed clusters were located at bands, where genes for the chromosome instability syndromes have been mapped to.</s><s>Additionally, a cluster was detected at 14q32, which is known to be a preferential site of chromosomal breakage in ataxiatelangiectasia patients <ref type="bibr" target="#b31">[32]</ref>.</s><s>The genes involved in the chromosome instability syndromes like Ataxia teleangiectasia or Fanconi anemia are critical in the early detection of induced damage and subsequent induction of cellular response to repair the damage <ref type="bibr" target="#b12">[13,</ref><ref type="bibr" target="#b32">33]</ref>.</s><s>Patients with these or other related disorders have a dramatically increased malignancy risk <ref type="bibr" target="#b32">[33]</ref>.</s><s>An interesting task for future studies would be to compare known gene loci and breakpoints in these cancer-prone disorders with radiation-induced aberrations with molecular tools.</s><s>We hypothesize, that a congruence of breakpoints induced by radiation with chromosomal breakage sites in chromosome instability syndromes would support the concept of radiation-induced instability through disturbances in DNA repair as suggested by others <ref type="bibr" target="#b12">[13]</ref>.</s></p><p><s>Due to the limited number of patients in our experimental study, the rates of secondary malignancies cannot be compared with large register data <ref type="bibr" target="#b0">[1]</ref><ref type="bibr" target="#b1">[2]</ref><ref type="bibr" target="#b2">[3]</ref><ref type="bibr" target="#b3">[4]</ref><ref type="bibr" target="#b4">[5]</ref><ref type="bibr" target="#b5">[6]</ref><ref type="bibr" target="#b6">[7]</ref>, although the 20 % cumulative incidence of secondary malignancies seems rather high.</s><s>As virtually all patients had cytogenetic aberrations in skin, additional cellular mechanisms must be involved in carcinogenesis in these patients.</s><s>It also seems very likely, that Legend to Table <ref type="table" target="#tab_2">3</ref>: Physical length of chromosome arms is given in Mb = Megabases according to <ref type="bibr" target="#b27">[28]</ref>.</s><s>Distribution of breakpoints is shown for chromosome arms and for whole chromosomes.</s><s>In a few cases (mainly due to derivative chromosomes), breakpoints could only be localized to a chromosome, but not to a certain chromosome arm.</s><s>Distribution of the breakpoints on the shorter chromosomes 16-22 and Y (chromosome groups E-G) is only shown for the whole chromosome and not for chromosome arms organ-specific cellular changes are involved in organ carcinogenesis.</s></p><p><s>More advanced technologies like FISH, SKY and molecular techniques have evolved rapidly with more data being available on mechanisms of cell damage and repair due to radiation injury <ref type="bibr" target="#b33">[34]</ref><ref type="bibr" target="#b34">[35]</ref><ref type="bibr" target="#b35">[36]</ref>.</s><s>These data, however, are either from cell culture systems and mice models or did not involve patients with TBI, while our data were from in vivo irradiated patients' fibroblasts.</s><s>Experimental approaches and organ-specific analyses might detect specific cytogenetic and molecular aberrations, which would increase our understanding of organ-specific radiationinduced cellular injury and carcinogenesis.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Fig. 1 Fig. 2</head><label>12</label><figDesc><div><p><s>Fig. 1 Percentage of different structural chromosomal aberrations in skin fibroblasts.</s><s>Legend to Fig. 1: chrom.</s><s>= chromosomes</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Fig. 3</head><label>3</label><figDesc><div><p><s>Fig. 3 Overview idiogram showing the distribution of all breakpoints in the retrospective study group.</s><s>Legend to Fig. 3: x: breakpoint from a translocation; • breakpoint from an aberration other than a translocation</s></p></div></figDesc><graphic coords="6,63.84,94.85,467.66,332.67" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1</head><label>1</label><figDesc><div><p><s>Patients' characteristics in the prospective and the retrospective study group</s></p></div></figDesc><table><row><cell></cell><cell>Prospective</cell><cell>Retrospective</cell></row><row><cell></cell><cell>group</cell><cell>group</cell></row><row><cell>Patients n</cell><cell>18</cell><cell>17</cell></row><row><cell>year of transplantation</cell><cell>1999-2001</cell><cell>1995-1999</cell></row><row><cell>Age at study entrymedian</cell><cell cols="2">37 years (16-49) 40 years (22-59)</cell></row><row><cell>(range)</cell><cell></cell><cell></cell></row><row><cell>Sex</cell><cell></cell><cell></cell></row><row><cell>male</cell><cell>12</cell><cell>8</cell></row><row><cell>female</cell><cell>6</cell><cell>9</cell></row><row><cell>Diagnosis</cell><cell></cell><cell></cell></row><row><cell>chronic myeloid leukemia</cell><cell>7</cell><cell>9</cell></row><row><cell>acute lymphoblastic leukemia</cell><cell>4</cell><cell>4</cell></row><row><cell>acute myelogenous leukemia</cell><cell>3</cell><cell>2</cell></row><row><cell>myelodysplastic syndrome</cell><cell>2</cell><cell>2</cell></row><row><cell>chronic myelomonocytic</cell><cell>1</cell><cell>0</cell></row><row><cell>leukemia</cell><cell></cell><cell></cell></row><row><cell>osteomyelofibrosis</cell><cell>1</cell><cell>0</cell></row><row><cell>Donor type</cell><cell>n = 17*</cell><cell></cell></row><row><cell>related</cell><cell>9</cell><cell>13</cell></row><row><cell>unrelated</cell><cell>8</cell><cell>4</cell></row><row><cell>HLA-match</cell><cell></cell><cell></cell></row><row><cell>HLA-identical</cell><cell>15</cell><cell>16</cell></row><row><cell>HLA-1-mismatch</cell><cell>2</cell><cell>1</cell></row><row><cell>Stem cell source</cell><cell></cell><cell></cell></row><row><cell>bone marrow</cell><cell>3</cell><cell>16</cell></row><row><cell>peripheral blood</cell><cell>14</cell><cell>1</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2</head><label>2</label><figDesc><div><p><s>Cytogenetic fibroblast analysis in the prospective and the retrospective study group</s></p></div></figDesc><table><row><cell>Study group</cell><cell>Prospective</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 3</head><label>3</label><figDesc><div><p><s>Number of different breakpoints and physical length of chromosomes</s></p></div></figDesc><table><row><cell>Chromosome/</cell><cell>Physical</cell><cell>Prospective group</cell><cell></cell><cell></cell><cell>Retrospective group</cell></row><row><cell>chromosome arm</cell><cell>length (Mb)</cell><cell>before SCT</cell><cell>after 3 months</cell><cell>after 12 months</cell><cell></cell></row><row><cell>1p</cell><cell>128</cell><cell>1</cell><cell>10</cell><cell>5</cell><cell>23</cell></row><row><cell>1q</cell><cell>135</cell><cell>1</cell><cell>3</cell><cell>23</cell><cell>16</cell></row><row><cell>1</cell><cell>263 (8,0 %)</cell><cell>3</cell><cell>13 (5,8 %)</cell><cell>30 (12,7 %)</cell><cell>39 (10,3 %)</cell></row><row><cell>2p</cell><cell>99</cell><cell>-</cell><cell>10</cell><cell>5</cell><cell>12</cell></row><row><cell>2q</cell><cell>156</cell><cell>-</cell><cell>12</cell><cell>9</cell><cell>15</cell></row><row><cell>2</cell><cell>255 (7,7 %)</cell><cell>-</cell><cell>22 (9,9 %)</cell><cell>14 (5,9 %)</cell><cell>27 (7,1 %)</cell></row><row><cell>3p</cell><cell>99</cell><cell>-</cell><cell>9</cell><cell>9</cell><cell>10</cell></row><row><cell>3q</cell><cell>115</cell><cell>-</cell><cell>10</cell><cell>9</cell><cell>14</cell></row><row><cell>3</cell><cell>214 (6,5 %)</cell><cell>-</cell><cell>19 (8,5 %)</cell><cell>19 (8,1 %)</cell><cell>24 (6,3 %)</cell></row><row><cell>4p</cell><cell>56</cell><cell>-</cell><cell>-</cell><cell>7</cell><cell>4</cell></row><row><cell>4q</cell><cell>147</cell><cell>-</cell><cell>7</cell><cell>5</cell><cell>15</cell></row><row><cell>4</cell><cell>203 (6,2 %)</cell><cell>-</cell><cell>7 (3,1 %)</cell><cell>12 (5,1 %)</cell><cell>21 (5,5 %)</cell></row><row><cell>5p</cell><cell>52</cell><cell>-</cell><cell>1</cell><cell>5</cell><cell>4</cell></row><row><cell>5q</cell><cell>142</cell><cell>1</cell><cell>12</cell><cell>3</cell><cell>15</cell></row><row><cell>5</cell><cell>194 (5,9 %)</cell><cell>1</cell><cell>13 (5,8 %)</cell><cell>9 (3,8 %)</cell><cell>21 (5,5 %)</cell></row><row><cell>6p</cell><cell>65</cell><cell>-</cell><cell>6</cell><cell>6</cell><cell>14</cell></row><row><cell>6q</cell><cell>118</cell><cell>-</cell><cell>9</cell><cell>6</cell><cell>6</cell></row><row><cell>6</cell><cell>183 (5,6 %)</cell><cell>-</cell><cell>15 (6,7 %)</cell><cell>12 (5,1 %)</cell><cell>21 (5,5 %)</cell></row><row><cell>7p</cell><cell>65</cell><cell>-</cell><cell>9</cell><cell>4</cell><cell>5</cell></row><row><cell>7q</cell><cell>106</cell><cell>-</cell><cell>9</cell><cell>5</cell><cell>10</cell></row><row><cell>7</cell><cell>171 (5,2 %)</cell><cell>-</cell><cell>18 (8,1 %)</cell><cell>9 (3,8 %)</cell><cell>15 (4,0 %)</cell></row><row><cell>8p</cell><cell>50</cell><cell>-</cell><cell>3</cell><cell>1</cell><cell>8</cell></row><row><cell>8q</cell><cell>105</cell><cell>-</cell><cell>4</cell><cell>4</cell><cell>13</cell></row><row><cell>8</cell><cell>155 (4,7 %)</cell><cell>-</cell><cell>7 (3,1 %)</cell><cell>5 (3,4 %)</cell><cell>21 (5,5 %)</cell></row><row><cell>9p</cell><cell>51</cell><cell>-</cell><cell>6</cell><cell>2</cell><cell>3</cell></row><row><cell>9q</cell><cell>94</cell><cell>-</cell><cell>5</cell><cell>4</cell><cell>15</cell></row><row><cell>9</cell><cell>145 (4,4 %)</cell><cell>-</cell><cell>11 (4,9 %)</cell><cell>6 (2,6 %)</cell><cell>18 (4.7 %)</cell></row><row><cell>10p</cell><cell>44</cell><cell>-</cell><cell>2</cell><cell>6</cell><cell>5</cell></row><row><cell>10q</cell><cell>100</cell><cell>-</cell><cell>6</cell><cell>6</cell><cell>15</cell></row><row><cell>10</cell><cell>144 (4,4 %)</cell><cell>-</cell><cell>9 (4,0 %)</cell><cell>12 (5,1 %)</cell><cell>22 (5,8 %)</cell></row><row><cell>11p</cell><cell>58</cell><cell>-</cell><cell>5</cell><cell>3</cell><cell>2</cell></row><row><cell>11q</cell><cell>86</cell><cell>-</cell><cell>5</cell><cell>7</cell><cell>6</cell></row><row><cell>11</cell><cell>144 (4,4 %)</cell><cell>-</cell><cell>10 (4,5 %)</cell><cell>10 (4,2 %)</cell><cell>9 (2,4 %)</cell></row><row><cell>12p</cell><cell>39</cell><cell>-</cell><cell>4</cell><cell>2</cell><cell>3</cell></row><row><cell>12q</cell><cell>104</cell><cell>1</cell><cell>4</cell><cell>5</cell><cell>6</cell></row><row><cell>12</cell><cell>143 (4,3 %)</cell><cell>1</cell><cell>8 (3,6 %)</cell><cell>7 (2,9 %)</cell><cell>9 (2,4 %)</cell></row><row><cell>13p</cell><cell>16</cell><cell>-</cell><cell>-</cell><cell>1</cell><cell>3</cell></row><row><cell>13q</cell><cell>98</cell><cell>-</cell><cell>7</cell><cell>9</cell><cell>11</cell></row><row><cell>13</cell><cell>114 (3,5 %)</cell><cell>-</cell><cell>8 (3,6 %)</cell><cell>11 (4,7 %)</cell><cell>14 (3,7 %)</cell></row><row><cell>14p</cell><cell>16</cell><cell>-</cell><cell>1</cell><cell>1</cell><cell>-</cell></row><row><cell>14q</cell><cell>93</cell><cell>1</cell><cell>9</cell><cell>13</cell><cell>20</cell></row><row><cell>14</cell><cell>109 (3,3 %)</cell><cell>1</cell><cell>11 (6,3 %)</cell><cell>14 (5,9 %)</cell><cell>22 (5,8 %)</cell></row><row><cell>15p</cell><cell>17</cell><cell>-</cell><cell>2</cell><cell>4</cell><cell>6</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 3</head><label>3</label><figDesc><div><p><s>Number of different breakpoints and physical length of chromosomes (Continued)</s></p></div></figDesc><table><row><cell>15q</cell><cell>89</cell><cell>-</cell><cell>6</cell><cell>7</cell><cell>9</cell></row><row><cell>15</cell><cell>106 (3,2 %)</cell><cell>-</cell><cell>9 (6,7 %)</cell><cell>11 (4,7 %)</cell><cell>15 (3,9 %)</cell></row><row><cell>16</cell><cell>98 (3,0 %)</cell><cell>-</cell><cell>10 (4,5 %)</cell><cell>9 (3,8 %)</cell><cell>16 (4,2 %)</cell></row><row><cell>17</cell><cell>92 (2,8 %)</cell><cell>1</cell><cell>8 (3,6 %)</cell><cell>6 (2,6 %)</cell><cell>16 (4,2 %)</cell></row><row><cell>18</cell><cell>85 (2,6 %)</cell><cell>1</cell><cell>5 (2,2 %)</cell><cell>6 (2,6 %)</cell><cell>12 (3,2 %)</cell></row><row><cell>19</cell><cell>67 (2,0 %)</cell><cell>-</cell><cell>6 (2,7 %)</cell><cell>4 (1,7 %)</cell><cell>6 (2,4 %)</cell></row><row><cell>20</cell><cell>72 (2,2 %)</cell><cell>-</cell><cell>6 (2,7 %)</cell><cell>7 (3,0 %)</cell><cell>10 (2,6 %)</cell></row><row><cell>21</cell><cell>50 (1,5 %)</cell><cell>1</cell><cell>5 (2,3 %)</cell><cell>5 (2,1 %)</cell><cell>2 (0,5 %)</cell></row><row><cell>22</cell><cell>56 (1,7 %)</cell><cell>1</cell><cell>3 (1,4 %)</cell><cell>5 (2,1 %)</cell><cell>3 (0,8 %)</cell></row><row><cell>Xp</cell><cell>62 (1,9 %)</cell><cell>-</cell><cell>-</cell><cell>4</cell><cell>10</cell></row><row><cell>Xq</cell><cell>102 (3,1 %)</cell><cell>-</cell><cell>1</cell><cell>6</cell><cell>10</cell></row><row><cell>X</cell><cell>164 (5,0 %)</cell><cell>-</cell><cell>2 (0,9 %)</cell><cell>10 (4,3 %)</cell><cell>22 (5,8 %)</cell></row><row><cell>Y</cell><cell>59 (1,8 %)</cell><cell>-</cell><cell>1 (0,5 %)</cell><cell>1 (0,4 %)</cell><cell>-</cell></row><row><cell>Sum of breakpoints:</cell><cell></cell><cell>10</cell><cell>222</cell><cell>235</cell><cell>379</cell></row></table></figure>
		</body>
		<back>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Competing interests</head><p><s>The authors declare, that they have no competing interests.</s></p><p><s>Authors' contribution G.M. designed the clinical trial, provided clinical specimens (skin biopsies), discussed the results and wrote the manuscript together with J.P. P.Z.</s><s>designed the methodological work-up, supervised and assisted laboratory analyses and performed cytogenetic analyses.</s><s>G.T. designed the experimental analysis and controlled cytogenetic analyses.</s><s>P.G.H. provided clinical data on clinical long-term follow-up and critically revised the manuscript.</s><s>V.B. supervised total body irradiation and provided clinical data from irradiated patients.</s><s>B.D. organized inter-institutional cooperation and added essential ideas to the project.</s><s>J.P. designed the clinical trial, carried out the laboratory analyses, performed cytogenetic analyses and wrote the manuscript together with G.M. J.P. and R.A. share senior authorship.</s><s>R.A. initiated the project, designed the clinical trial, provided clinical data and critically revised the manuscript.</s><s>R.A. and J.P. share senior authorship.</s><s>All authors read and approved the manuscript.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Witherspoon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">D</forename><surname>Fisher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Schoch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Sullivan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Sanders</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">321</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="784" to="789" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Malignant neoplasms in long-term-survivors of bone marrow transplantation</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Kolb</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Socié</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Duell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Van Lint</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Tichelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Apperley</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Intern Med</title>
		<imprint>
			<biblScope unit="volume">131</biblScope>
			<biblScope unit="page" from="738" to="744" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia</title>
		<author>
			<persName><forename type="first">G</forename><surname>Socié</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Curtis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Deeg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Sobocinski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">H</forename><surname>Filipovich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">B</forename><surname>Travis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Oncol</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="348" to="357" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Solid cancers after bone marrow transplantation</title>
		<author>
			<persName><forename type="first">S</forename><surname>Bhatia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Louie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bhatia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O'</forename><surname>Donnell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Fung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kashyap</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Oncol</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="464" to="471" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">New malignancies after blood or marrow stem-cell transplantation in children and adults: incidence and risk factors</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">S</forename><surname>Baker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">E</forename><surname>Defor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Burns</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">K</forename><surname>Ramsay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Neglia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">L</forename><surname>Robison</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Oncol</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page">3181</biblScope>
			<date type="published" when="2003">2003. 2003</date>
		</imprint>
	</monogr>
	<note>J Clin Oncol</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Long-term follow-up of secondary malignancies in adults after allogeneic bone marrow transplantation</title>
		<author>
			<persName><forename type="first">W</forename><surname>Hasegawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Pond</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Rifkind</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Messner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Daly</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bone Marrow Transplant</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="51" to="55" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Solid cancers after allogeneic hematopoietic cell transplantation</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Rizzo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Curtis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Socié</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Sobocinski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Gilbert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Landgren</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">113</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1175" to="1183" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Nonrandom Chromosomal Abnormalities in Acute Nonlymphocytic Leukemia in Patients Treated for Hodgkin Disease and Non-Hodgkin Lymphomas</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Rowley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">M</forename><surname>Golomb</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Vardiman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="759" to="770" />
			<date type="published" when="1977">1977</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Clinical and Cytogenetic Correlations in 63 Patients With Therapy-Related Myelodysplastic Syndromes and Acute Nonlymphocytic Leukemia: Further Evidence for Characteristic Abnormalities of Chromosomes No. 5 and 7</title>
		<author>
			<persName><forename type="first">Le</forename><surname>Beau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Albain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">S</forename><surname>Larson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Vardiman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Davis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Blough</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">R</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Oncol</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="325" to="345" />
			<date type="published" when="1986">1986</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Genetics of therapy-related myelodysplasia and acute myeloid leukemia</title>
		<author>
			<persName><forename type="first">J</forename><surname>Pedersen-Bjergaard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Andersen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Andersen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Christiansen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Leukemia</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="240" to="248" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Therapy-related myeloid neoplasms following treatment with radioiodine</title>
		<author>
			<persName><forename type="first">T</forename><surname>Schroeder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kuendgen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kayser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Kröger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Braulke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Platzbecker</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Haematologica</title>
		<imprint>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="206" to="212" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Cytogenetic study of eight new cases of radiation-induced solid tumors</title>
		<author>
			<persName><forename type="first">L</forename><surname>Chauveinc</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Dutrillaux</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Validire</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Padoy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Sabatier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Couturier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Genet Cytogenet</title>
		<imprint>
			<biblScope unit="volume">114</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="1" to="8" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Radiation-induced genomic instability and its implications for radiation carcinogenesis</title>
		<author>
			<persName><forename type="first">L</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Snyder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">F</forename><surname>Morgan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncogene</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">37</biblScope>
			<biblScope unit="page" from="5848" to="5854" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Indirect mechanisms of genomic instability and the biological significance of mutations at tandem repeat loci</title>
		<author>
			<persName><forename type="first">O</forename><surname>Niwa</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mutat Res</title>
		<imprint>
			<biblScope unit="volume">598</biblScope>
			<biblScope unit="issue">1-2</biblScope>
			<biblScope unit="page" from="61" to="72" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Cytogenetic study of skin fibroblasts in a case of accidental acute irradiation</title>
		<author>
			<persName><forename type="first">M</forename><surname>Mouthuy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Dutrillaux</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mutat Res</title>
		<imprint>
			<biblScope unit="volume">95</biblScope>
			<biblScope unit="page" from="19" to="30" />
			<date type="published" when="1982">1982</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Clonal fibroblastic cell lines established from a heavily exposed atomic bomb survivor</title>
		<author>
			<persName><forename type="first">T</forename><surname>Honda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Sadamori</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Itoh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Kusumi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mutat Res</title>
		<imprint>
			<biblScope unit="volume">291</biblScope>
			<biblScope unit="page" from="125" to="133" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Blood and skin chromosomal alterations of a clonal type in a leukemic man previously irradiated for a lung carcinoma</title>
		<author>
			<persName><forename type="first">E</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Flexner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Engel-De Montmollin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">E</forename><surname>Frank</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cytogenetics</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="228" to="251" />
			<date type="published" when="1964">1964</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Aberration distribution and chromosomally marked clones in x-irradiated skin</title>
		<author>
			<persName><forename type="first">Jrk</forename><surname>Savage</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Trl</forename><surname>Bigger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Mutagen-Induced Chromosome Damage in Man</title>
				<editor>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Evans</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Lloyd</surname></persName>
		</editor>
		<meeting><address><addrLine>Edinburgh</addrLine></address></meeting>
		<imprint>
			<publisher>Edinburgh University Press</publisher>
			<date type="published" when="1978">1978</date>
			<biblScope unit="page" from="155" to="169" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Chromosomal abnormalities in skin following total body or total lymphoid irradiation</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Rubin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Nesbit</surname><genName>Jr</genName></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">H</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Kersey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Arthur</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genes Chrom Cancer</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="141" to="145" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">High-dose preparatory regimens</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">I</forename><surname>Bensinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">F</forename><surname>Appelbaum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Forman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Negrin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">G</forename><surname>Blume</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Thomas&apos; Hematopoietic Cell Transplantation</title>
				<meeting><address><addrLine>USA</addrLine></address></meeting>
		<imprint>
			<publisher>Wiley-Blackwell NY</publisher>
			<date type="published" when="2011">2011</date>
			<biblScope unit="page" from="316" to="332" />
		</imprint>
	</monogr>
	<note>4th ed.</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">The culture of skin. A review of theories and experimental methods</title>
		<author>
			<persName><forename type="first">M</forename><surname>Pruniéras</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Delescluse</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Regnier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Invest Dermatol</title>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="58" to="65" />
			<date type="published" when="1976">1976</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Growth rate of control and betainterferon-treated human fibroblast populations over the course of their in vitro life span</title>
		<author>
			<persName><forename type="first">I</forename><surname>Tamm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kikuchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Pfeffer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="2291" to="2296" />
			<date type="published" when="1984">1984</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">A rapid banding technique for human chromosomes</title>
		<author>
			<persName><forename type="first">M</forename><surname>Seabright</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="issue">7731</biblScope>
			<biblScope unit="page" from="971" to="972" />
			<date type="published" when="1971">1971</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">An International System for Human Cytogenetic Nomenclature</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">G</forename><surname>Shaffer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mcgowan-Jordan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Schmid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Basel</surname></persName>
		</author>
		<author>
			<persName><surname>Karger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">ISCN</title>
		<imprint>
			<date type="published" when="2013">2013. 2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Clone formation in tissue culture</title>
		<author>
			<persName><forename type="first">J</forename><surname>Visfeldt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Pathol Microbiol Scand</title>
		<imprint>
			<biblScope unit="volume">68</biblScope>
			<biblScope unit="page" from="305" to="312" />
			<date type="published" when="1966">1966</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Is there a simple answer to the origin of complex chromosome exchanges?</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Edwards</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jrk</forename><surname>Savage</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Radiat Biol</title>
		<imprint>
			<biblScope unit="volume">75</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="19" to="22" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Site specific chromosomal rearrangements induced in human diploid cells by X irradiation</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Kano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Little</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cytogenet Cell Genet</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="22" to="29" />
			<date type="published" when="1986">1986</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Parameters of the human genome</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">E</forename><surname>Morton</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci U S A</title>
		<imprint>
			<biblScope unit="volume">88</biblScope>
			<biblScope unit="page" from="7474" to="7476" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Radiation-induced genomic instability</title>
		<author>
			<persName><forename type="first">A</forename><surname>Kronenberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Radiat Biol</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="603" to="609" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">The pattern of radiation induced transmissible aberrations in a human cell culture</title>
		<author>
			<persName><forename type="first">Cly</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">P</forename><surname>Kamra</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hum Genet</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="380" to="384" />
			<date type="published" when="1981">1981</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Radiation-induced breakpoint misrejoining in human chromosomes: random or non-random?</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Brenner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Nath</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Tucker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Geard</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Radiat Biol</title>
		<imprint>
			<biblScope unit="volume">75</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="131" to="141" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Chromosome Instability Syndromes</title>
		<author>
			<persName><forename type="first">Mckinlay</forename><surname>Gardner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Sutherland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Chromosome Abnormalities and Genetic Counseling. Oxford Monographs on Medical Genetics</title>
		<imprint>
			<biblScope unit="issue">46</biblScope>
			<biblScope unit="page" from="301" to="308" />
			<date type="published" when="2004">2004</date>
			<publisher>Oxford University Press</publisher>
		</imprint>
	</monogr>
	<note>3rd ed</note>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Chromosome instability syndromes</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Taylor</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Best Pract Res Clin Haematol</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="631" to="644" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Secondary Radiation-Induced Bone Tumours Demonstrate a High Degree of Genomic Instability Predictive of a Poor Prognosis</title>
		<author>
			<persName><forename type="first">C</forename><surname>Rümenapp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Smida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Gonzalez-Vasconcellos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Baumhoer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Malfoy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">S</forename><surname>Hadj-Hamou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Genomics</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="433" to="437" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Radiation carcinogenesis</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Little</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Carcinogenesis</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="397" to="404" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">A Role for Mitochondrial Dysfunction in Perpetuating Radiation-Induced Genomic Instability</title>
		<author>
			<persName><forename type="first">J</forename><surname>Grace</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">J</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Fiskum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">F</forename><surname>Morgan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="issue">21</biblScope>
			<biblScope unit="page" from="10377" to="10383" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
